Metabolic Dysfunction–Associated Steatotic Liver Disease (MASLD)

Metabolic Dysfunction–Associated Steatotic Liver Disease (MASLD) is increasingly associated with metabolic risk factors such as obesity, diabetes mellitus, hypertension, and dyslipidemia, and can progress silently to advanced liver disease if not identified early. As per the Global Burden of Disease (GBD) Study 2023, the prevalence of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in India is 12.74%, while Tamil Nadu records a notably higher prevalence of ,16.09%, highlighting the greater burden of this condition in the State. Since the condition is often asymptomatic in its initial stages, early screening and risk stratification are essential for timely intervention and management.